Search Results - "Yilmaz Enc, Feruze"

The role of myocardial performance index and Nt-proBNP levels as a marker of heart dysfunction in nonalcoholic cirrhotic patients by TOKAY TARHAN, Sena, YILMAZ ENÇ, Feruze, EREN, Fatih, FAK, Ali Serdar, ÖZDOĞAN, Osman

“…Objective: Cardiac dysfunction has been reported in both cirrhotic and alcoholic patients. Our aim was to determine the relation of serum N-terminal pro-B-type…”
Get full text

Parvovirus-induced autoimmune hepatitis: First case in the literature by YAVUZ, Arda, TOKSOZ YILDIRIM, Ayse Nur, YILMAZ ENC, Feruze, TUNCER, Ilyas

“…Parvovirus B19 infection is usually self-limiting in immunocompetent individuals. Twenty-five percent of infected individuals are completely asymptomatic…”
Get full text

Association of human leukocyte antigen DQB1 and DRB1 alleles with chronic hepatitis B by Doganay, Levent, Fejzullahu, Arta, Katrinli, Seyma, Yilmaz Enc, Feruze, Ozturk, Oguzhan, Colak, Yasar, Ulasoglu, Celal, Tuncer, Ilyas, Dinler Doganay, Gizem

“…AIM: To investigate the effect of human leukocyte antigen(HLA) DRB1 and DQB1 alleles on the inactive and advanced stages of chronic hepatitis B.METHODS:…”
Get full text

Extracellular matrix protein 1 gene rs3737240 single nucleotide polymorphism is associated with ulcerative colitis in Turkish patients by Adalı, Gupse, Ersoy Tunalı, Nagehan, Yorulmaz, Elif, Tiryakioğlu, Necip Ozan, Mungan, Sibel Güray, Ulaşoğlu, Celal, Yılmaz Enç, Feruze, Tuncer, İlyas

“…Ulcerative colitis (UC) and Crohn's disease are chronic inflammatory diseases. Genetic, immunologic, and microbial factors play an important role in their…”
Get full text

Evaluation of depression, anxiety, alexithymia, attachment, social support and somatization in functional dyspepsia by Kani, Haluk Tarik, Dural, Uzay, Sakalli Kani, Ayse, Yanartas, Omer, Kiziltas, Safak, Yilmaz Enc, Feruze, Atug, Ozlen, Deyneli, Oguzhan, Kuscu, Kemal, Imeryuz, Nese

“…AIM: The psychiatric and psychosocial aetiology of Functional dyspepsia is not well known. In the present study, our aim is to determine the relative…”
Get full text

SIRT1 as a potential therapeutic target for treatment of nonalcoholic fatty liver disease by Colak, Yasar, Ozturk, Oguzhan, Senates, Ebubekir, Tuncer, Ilyas, Yorulmaz, Elif, Adali, Gupse, Doganay, Levent, Enc, Feruze Yilmaz

“…Sirtuins are members of the silent information regulator 2 (Sir2) family, a group of Class III histone/protein deacetylases. There are 7 different sirtuins in…”
Get full text

A potential treatment of non-alcoholic fatty liver disease with SIRT1 activators by Colak, Yasar, Yesil, Atakan, Mutlu, Hasan Huseyin, Caklili, Ozge Telci, Ulasoglu, Celal, Senates, Ebubekir, Takir, Mumtaz, Kostek, Osman, Yilmaz, Yusuf, Yilmaz Enc, Feruze, Tasan, Guralp, Tuncer, Ilyas

“…Sirtuins (SIRTs) are members of the silent information regulator-2 family and act as nicotinamide adenine dinucleotide (NAD+)-dependent histone/protein…”
Get more information

Relation of epicardial adipose tissue and carotid intima-media thickness in patients with nonalcoholic fatty liver disease by Colak, Yasar, Karabay, Can Yucel, Tuncer, Ilyas, Kocabay, Gonenc, Kalayci, Arzu, Senates, Ebubekir, Ozturk, Oguzhan, Doganay, Hamdi Levent, Enc, Feruze Yilmaz, Ulasoglu, Celal, Kiziltas, Safak

“…OBJECTIVECurrently, nonalcoholic fatty liver disease (NAFLD) itself has been accepted as an atherosclerotic risk factor and related to increased cardiovascular…”
Get full text

The Change in the Susceptible Populations with the Shift in Hepatitis A Epidemiology by SİRİN, Abdullatif, TOKMAK, Salih, AKAN, Kübra, ULAŞOĞLU, Celal, ENÇ, Feruze

“…Aim: The incidence of hepatitis A (HepA) has decreased due to vaccination and improved hygiene conditions. However, the age of onset of the disease has shifted…”
Get full text

Therapeutic success with bismuth-containing sequential and quadruple regimens in Helicobacter pylori eradication by Ozturk, Oguzhan, Doganay, Levent, Colak, Yasar, Yilmaz Enc, Feruze, Ulasoglu, Celal, Ozdil, Kamil, Tuncer, Ilyas

“…The success rate of Helicobacter pylori (H. pylori) eradication with the classical triple therapy is gradually declining. In this study, we aimed to compare…”
Get full text

Serum concentrations of human insulin-like growth factor-1 and levels of insulin-like growth factor-binding protein-5 in patients with nonalcoholic fatty liver disease: association with liver histology by Colak, Yasar, Senates, Ebubekir, Ozturk, Oguzhan, Yilmaz, Yusuf, Zemheri, Ebru, Yilmaz Enc, Feruze, Ulasoglu, Celal, Aksaray, Sebahat, Bozbeyoglu, Sabriye Gulcin, Kiziltas, Safak, Kurdas, Oya Ovunc, Tuncer, Ilyas

“…OBJECTIVEIn this study, we aimed to investigate the relationship between the histological features of nonalcoholic fatty liver disease (NAFLD) and serum…”
Get full text

A Potential Treatment of Non-Alcoholic Fatty Liver Disease with SIRT1 Activators by Colak, Yasar, Yesil, Atakan, Mutlu, Hasan Huseyin, Caklili, Ozge Telci, Ulasoglu, Celal, Senates, Ebubekir, Takir, Mumtaz, Kostek, Osman, Yilmaz, Yusuf, Enc, Feruze Yilmaz, Tasan, Guralp, Tuncer, Ilyas

“…Sirtuins (SIRTs) are members of the silent information regulator-2 family and act as nicotinamide adenine dinucleotide (NAD+)-dependent histone/protein…”
Get full text

Impaired Gallbladder Motility and Increased Gallbladder Wall Thickness in Patients with Nonalcoholic Fatty Liver Disease by Colak, Yasar, Bozbey, Gulcin, Erim, Tolga, Caklili, Ozge Telci, Ulasoglu, Celal, Senates, Ebubekir, Mutlu, Hasan Huseyin, Mesci, Banu, Doğan, Mehmet Sait, Tasan, Guralp, Enc, Feruze Yilmaz, Tuncer, Ilyas

“…Nonalcoholic fatty liver disease (NAFLD) is currently the most common chronic liver disease worldwide. Along with the increase in the incidence of NAFLD and…”
Get full text

Plasma fibrinogen-like protein 2 levels in patients with non-alcoholic fatty liver disease by Colak, Yasar, Senates, Ebubekir, Ozturk, Oguzhan, Yilmaz, Yusuf, Coskunpinar, Ender, Kahraman, Ozlem Timirci, Sahin, Onder, Zemheri, Ebru, Enc, Feruze Yilmaz, Ulasoglu, Celal, Kiziltas, Safak, Kurdas, Oya Ovunc, Tuncer, Ilyas

“…Fibrinogen-like protein 2 (fgl2), has recently been identified as a new member of the fibrinogen-like family of proteins. In this study we assayed plasma…”
Get more information

Orlistat accelerates gastric emptying and attenuates GIP release in healthy subjects by Enç, Feruze Yilmaz, Ones, Tunç, Akin, H Levent, Dede, Fuat, Turoğlu, H Turgut, Ulfer, Gözde, Bekiroğlu, Nural, Haklar, Goncagül, Rehfeld, Jens F, Holst, Jens J, Ulusoy, Nefise B, Imeryüz, Neşe

“…Orlistat, an inhibitor of digestive lipases, is widely used for the treatment of obesity. Previous reports on the effect of orally ingested orlistat together…”
Get more information

Characterization of Patients with Biopsy-Proven Non-Alcoholic Fatty Liver Disease and Normal Aminotransferase Levels by Ulasoglu, Celal, Enc, Feruze Yilmaz, Kaya, Eda, Yilmaz, Yusuf

“…Background and Aims: Non-alcoholic fatty liver disease (NAFLD) is one of the major causes of abnormal liver function tests in hepatology practice. However, not…”
Get full text

The interaction between current smoking and hemoglobin on the risk of advanced fibrosis in patients with biopsy-proven nonalcoholic fatty liver disease by Enc, Feruze Yilmaz, Ulasoglu, Celal, Bakir, Alev, Yilmaz, Yusuf

“…BACKGROUNDHigher hemoglobin levels have been associated with an increased risk for nonalcoholic fatty liver disease. Although the mechanism underlying this…”
Get full text

HLA DQB1 alleles are related with nonalcoholic fatty liver disease by Doganay, Levent, Katrinli, Seyma, Colak, Yasar, Senates, Ebubekir, Zemheri, Ebru, Ozturk, Oguzhan, Enc, Feruze Yilmaz, Tuncer, Ilyas, Doganay, Gizem Dinler

“…Nonalcoholic fatty liver disease (NAFLD) is the leading cause of chronic liver disease. NAFLD is a complex disease and inflammation is a crucial component in…”
Get full text

The effect of HLA-DQB1 alleles on virologic breakthroughs during chronic hepatitis B treatment with genetically low barrier drugs by Doganay, Levent, Tuncer, Ilyas, Katrinli, Seyma, Enc, Feruze Yilmaz, Ozturk, Oguzhan, Colak, Yasar, Ulasoglu, Celal, Dinler, Gizem

“…Summary Background Chronic hepatitis B treatment with oral antiviral drugs is a long course. During this course, antiviral resistance is a serious issue,…”
Get full text

Concentrations of connective tissue growth factor in patients with nonalcoholic fatty liver disease: association with liver fibrosis by Colak, Yasar, Senates, Ebubekir, Coskunpinar, Ender, Oltulu, Yasemin Musteri, Zemheri, Ebru, Ozturk, Oguzhan, Doganay, Levent, Mesci, Banu, Yilmaz, Yusuf, Enc, Feruze Yilmaz, Kiziltas, Safak, Ulasoglu, Celal, Tuncer, Ilyas

“…In this study, we aimed to investigate the relationship between the histological fibrosis stage of nonalcoholic fatty liver disease (NAFLD) and serum…”
Get full text